Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Aurinia Pharmaceuticals Stock Quote

Aurinia Pharmaceuticals (NASDAQ: AUPH)

Price as of July 16, 2024, 11:26 a.m. ET

Aurinia Pharmaceuticals Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
AUPH -49.01% -10.71% -2.24% +177%
S&P +24.51% +86.32% +13.24% +298%

Aurinia Pharmaceuticals Company Info

Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

News & Analysis

The Fool has written over 100 articles on Aurinia Pharmaceuticals.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.